Patient_ID
stringlengths 8
8
| Age
int64 18
89
| Gender
stringclasses 2
values | Weight_kg
float64 50.2
100
| Height_cm
float64 150
200
| Comorbidities
stringclasses 4
values | Previous_Treatments
stringclasses 3
values | Tumor_Histology
stringclasses 4
values | Tumor_Grade
stringclasses 3
values | Tumor_Stage
stringclasses 4
values | Imaging_Modality
stringclasses 3
values | Image_Resolution
stringclasses 2
values | Scan_Type
stringclasses 2
values | Scanner_Manufacturer
stringclasses 3
values | Gross_Tumor_Volume_cm3
float64 1.22
150
| Clinical_Target_Volume_cm3
float64 0.96
200
| Planning_Target_Volume_cm3
float64 1.47
249
| Beam_Arrangements
stringclasses 2
values | Dose_Distributions_Gy
float64 10.2
99.8
| Optimization_Objectives
stringclasses 3
values | Dose_Volume_Histogram
stringlengths 9
9
| Synthetic_Image_Path
stringlengths 41
41
| GTV_Segmentation_Path
stringlengths 45
45
| CTV_Segmentation_Path
stringlengths 45
45
| PTV_Segmentation_Path
stringlengths 45
45
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
SIM-0201 | 34 | Male | 93.1 | 198.9 | Diabetes | null | Glioblastoma | Intermediate | III | CT | Anisotropic | Non-Contrast-Enhanced | GE | 110.29 | 97.45 | 180.76 | Single | 70.36 | Maximize Tumor Dose | DVH_P0201 | /simulated/path/P0201_synthetic_image.nii | /simulated/path/SIM-0201_GTV_segmentation.nii | /simulated/path/SIM-0201_CTV_segmentation.nii | /simulated/path/SIM-0201_PTV_segmentation.nii |
SIM-0202 | 83 | Male | 87.6 | 196.3 | Cancer History | Surgery | Glioblastoma | Low | I | MRI | Isotropic | Contrast-Enhanced | GE | 16.49 | 27.96 | 223.72 | Multi-Beam | 28.63 | Balanced | DVH_P0202 | /simulated/path/P0202_synthetic_image.nii | /simulated/path/SIM-0202_GTV_segmentation.nii | /simulated/path/SIM-0202_CTV_segmentation.nii | /simulated/path/SIM-0202_PTV_segmentation.nii |
SIM-0203 | 60 | Female | 90.3 | 192.4 | null | Surgery | Meningioma | Low | I | PET | Anisotropic | Contrast-Enhanced | Siemens | 70.36 | 118.47 | 42.68 | Single | 20.76 | Organ-Sparing | DVH_P0203 | /simulated/path/P0203_synthetic_image.nii | /simulated/path/SIM-0203_GTV_segmentation.nii | /simulated/path/SIM-0203_CTV_segmentation.nii | /simulated/path/SIM-0203_PTV_segmentation.nii |
SIM-0204 | 44 | Male | 78 | 185.9 | Hypertension | null | Glioblastoma | High | I | PET | Anisotropic | Contrast-Enhanced | Siemens | 123.95 | 133.23 | 202.34 | Single | 22.06 | Organ-Sparing | DVH_P0204 | /simulated/path/P0204_synthetic_image.nii | /simulated/path/SIM-0204_GTV_segmentation.nii | /simulated/path/SIM-0204_CTV_segmentation.nii | /simulated/path/SIM-0204_PTV_segmentation.nii |
SIM-0205 | 79 | Female | 55.5 | 193 | null | Chemotherapy | Glioblastoma | Intermediate | I | CT | Isotropic | Contrast-Enhanced | GE | 76.36 | 129.21 | 226.63 | Single | 86.91 | Balanced | DVH_P0205 | /simulated/path/P0205_synthetic_image.nii | /simulated/path/SIM-0205_GTV_segmentation.nii | /simulated/path/SIM-0205_CTV_segmentation.nii | /simulated/path/SIM-0205_PTV_segmentation.nii |
SIM-0206 | 41 | Female | 72.9 | 198.6 | Hypertension | Surgery | Meningioma | Intermediate | I | MRI | Anisotropic | Non-Contrast-Enhanced | Philips | 142.58 | 33.18 | 14.62 | Single | 75.51 | Maximize Tumor Dose | DVH_P0206 | /simulated/path/P0206_synthetic_image.nii | /simulated/path/SIM-0206_GTV_segmentation.nii | /simulated/path/SIM-0206_CTV_segmentation.nii | /simulated/path/SIM-0206_PTV_segmentation.nii |
SIM-0207 | 62 | Male | 99.9 | 151.4 | Cardiac Issues | Surgery | Astrocytoma | Intermediate | IV | PET | Isotropic | Contrast-Enhanced | Philips | 64.98 | 15.23 | 138.37 | Single | 85.84 | Maximize Tumor Dose | DVH_P0207 | /simulated/path/P0207_synthetic_image.nii | /simulated/path/SIM-0207_GTV_segmentation.nii | /simulated/path/SIM-0207_CTV_segmentation.nii | /simulated/path/SIM-0207_PTV_segmentation.nii |
SIM-0208 | 20 | Female | 80.5 | 199.7 | null | Chemotherapy | Meningioma | High | IV | CT | Isotropic | Non-Contrast-Enhanced | Siemens | 67.75 | 87.86 | 182.23 | Single | 10.54 | Balanced | DVH_P0208 | /simulated/path/P0208_synthetic_image.nii | /simulated/path/SIM-0208_GTV_segmentation.nii | /simulated/path/SIM-0208_CTV_segmentation.nii | /simulated/path/SIM-0208_PTV_segmentation.nii |
SIM-0209 | 79 | Male | 54.6 | 183.8 | Diabetes | Radiotherapy | Glioblastoma | Low | II | PET | Anisotropic | Non-Contrast-Enhanced | GE | 103.48 | 191.29 | 227.47 | Multi-Beam | 43.97 | Balanced | DVH_P0209 | /simulated/path/P0209_synthetic_image.nii | /simulated/path/SIM-0209_GTV_segmentation.nii | /simulated/path/SIM-0209_CTV_segmentation.nii | /simulated/path/SIM-0209_PTV_segmentation.nii |
SIM-0210 | 34 | Male | 68 | 166.5 | Diabetes | Radiotherapy | Metastatic | High | III | MRI | Isotropic | Contrast-Enhanced | GE | 42.12 | 112.49 | 57.33 | Single | 69.25 | Maximize Tumor Dose | DVH_P0210 | /simulated/path/P0210_synthetic_image.nii | /simulated/path/SIM-0210_GTV_segmentation.nii | /simulated/path/SIM-0210_CTV_segmentation.nii | /simulated/path/SIM-0210_PTV_segmentation.nii |
SIM-0211 | 21 | Female | 77 | 155.6 | Hypertension | Surgery | Metastatic | Intermediate | IV | MRI | Isotropic | Non-Contrast-Enhanced | Siemens | 10.41 | 140.91 | 51.36 | Single | 66.52 | Maximize Tumor Dose | DVH_P0211 | /simulated/path/P0211_synthetic_image.nii | /simulated/path/SIM-0211_GTV_segmentation.nii | /simulated/path/SIM-0211_CTV_segmentation.nii | /simulated/path/SIM-0211_PTV_segmentation.nii |
SIM-0212 | 68 | Male | 63 | 150.8 | Hypertension | Surgery | Meningioma | High | IV | PET | Isotropic | Non-Contrast-Enhanced | GE | 116.12 | 168.6 | 101.99 | Single | 14.57 | Organ-Sparing | DVH_P0212 | /simulated/path/P0212_synthetic_image.nii | /simulated/path/SIM-0212_GTV_segmentation.nii | /simulated/path/SIM-0212_CTV_segmentation.nii | /simulated/path/SIM-0212_PTV_segmentation.nii |
SIM-0213 | 72 | Female | 56.8 | 185.9 | Hypertension | Surgery | Meningioma | Intermediate | III | MRI | Isotropic | Non-Contrast-Enhanced | GE | 8.43 | 149.25 | 101.6 | Multi-Beam | 62.66 | Organ-Sparing | DVH_P0213 | /simulated/path/P0213_synthetic_image.nii | /simulated/path/SIM-0213_GTV_segmentation.nii | /simulated/path/SIM-0213_CTV_segmentation.nii | /simulated/path/SIM-0213_PTV_segmentation.nii |
SIM-0214 | 76 | Female | 82.8 | 150.4 | Cardiac Issues | null | Astrocytoma | Intermediate | II | CT | Anisotropic | Non-Contrast-Enhanced | GE | 25.18 | 49.54 | 215.86 | Single | 99.83 | Balanced | DVH_P0214 | /simulated/path/P0214_synthetic_image.nii | /simulated/path/SIM-0214_GTV_segmentation.nii | /simulated/path/SIM-0214_CTV_segmentation.nii | /simulated/path/SIM-0214_PTV_segmentation.nii |
SIM-0215 | 47 | Female | 88.8 | 184 | Cancer History | Surgery | Metastatic | Low | I | MRI | Isotropic | Non-Contrast-Enhanced | GE | 88.02 | 53.18 | 62.97 | Single | 65.9 | Balanced | DVH_P0215 | /simulated/path/P0215_synthetic_image.nii | /simulated/path/SIM-0215_GTV_segmentation.nii | /simulated/path/SIM-0215_CTV_segmentation.nii | /simulated/path/SIM-0215_PTV_segmentation.nii |
SIM-0216 | 35 | Female | 58.2 | 198.1 | null | null | Meningioma | Low | IV | MRI | Isotropic | Contrast-Enhanced | GE | 137.97 | 38.71 | 133.68 | Single | 11.54 | Balanced | DVH_P0216 | /simulated/path/P0216_synthetic_image.nii | /simulated/path/SIM-0216_GTV_segmentation.nii | /simulated/path/SIM-0216_CTV_segmentation.nii | /simulated/path/SIM-0216_PTV_segmentation.nii |
SIM-0217 | 21 | Female | 69.3 | 191.9 | null | Surgery | Glioblastoma | Intermediate | I | CT | Anisotropic | Non-Contrast-Enhanced | Siemens | 57.44 | 134.47 | 110.54 | Single | 25.49 | Balanced | DVH_P0217 | /simulated/path/P0217_synthetic_image.nii | /simulated/path/SIM-0217_GTV_segmentation.nii | /simulated/path/SIM-0217_CTV_segmentation.nii | /simulated/path/SIM-0217_PTV_segmentation.nii |
SIM-0218 | 86 | Male | 78.1 | 176.8 | Hypertension | Chemotherapy | Glioblastoma | High | I | MRI | Anisotropic | Non-Contrast-Enhanced | Siemens | 14.33 | 2.49 | 147.75 | Single | 66.1 | Organ-Sparing | DVH_P0218 | /simulated/path/P0218_synthetic_image.nii | /simulated/path/SIM-0218_GTV_segmentation.nii | /simulated/path/SIM-0218_CTV_segmentation.nii | /simulated/path/SIM-0218_PTV_segmentation.nii |
SIM-0219 | 82 | Male | 78.2 | 199.4 | Cancer History | Surgery | Astrocytoma | Low | I | CT | Isotropic | Non-Contrast-Enhanced | GE | 126.64 | 164.38 | 27.77 | Single | 37.46 | Organ-Sparing | DVH_P0219 | /simulated/path/P0219_synthetic_image.nii | /simulated/path/SIM-0219_GTV_segmentation.nii | /simulated/path/SIM-0219_CTV_segmentation.nii | /simulated/path/SIM-0219_PTV_segmentation.nii |
SIM-0220 | 42 | Female | 65.3 | 180.5 | Hypertension | null | Meningioma | High | II | CT | Anisotropic | Contrast-Enhanced | Siemens | 126.97 | 14.56 | 184.58 | Multi-Beam | 99.08 | Balanced | DVH_P0220 | /simulated/path/P0220_synthetic_image.nii | /simulated/path/SIM-0220_GTV_segmentation.nii | /simulated/path/SIM-0220_CTV_segmentation.nii | /simulated/path/SIM-0220_PTV_segmentation.nii |
SIM-0221 | 64 | Female | 65.8 | 172.7 | Cardiac Issues | Radiotherapy | Metastatic | Low | III | PET | Anisotropic | Contrast-Enhanced | Philips | 100.13 | 192.71 | 232.03 | Single | 63.83 | Maximize Tumor Dose | DVH_P0221 | /simulated/path/P0221_synthetic_image.nii | /simulated/path/SIM-0221_GTV_segmentation.nii | /simulated/path/SIM-0221_CTV_segmentation.nii | /simulated/path/SIM-0221_PTV_segmentation.nii |
SIM-0222 | 83 | Male | 61.7 | 183.5 | Diabetes | Radiotherapy | Astrocytoma | High | IV | CT | Isotropic | Non-Contrast-Enhanced | Siemens | 137.68 | 30.89 | 190.61 | Single | 60.38 | Maximize Tumor Dose | DVH_P0222 | /simulated/path/P0222_synthetic_image.nii | /simulated/path/SIM-0222_GTV_segmentation.nii | /simulated/path/SIM-0222_CTV_segmentation.nii | /simulated/path/SIM-0222_PTV_segmentation.nii |
SIM-0223 | 32 | Female | 54.8 | 160.3 | Cancer History | null | Glioblastoma | Intermediate | III | MRI | Isotropic | Contrast-Enhanced | Philips | 90.89 | 108.95 | 130.14 | Multi-Beam | 48.71 | Maximize Tumor Dose | DVH_P0223 | /simulated/path/P0223_synthetic_image.nii | /simulated/path/SIM-0223_GTV_segmentation.nii | /simulated/path/SIM-0223_CTV_segmentation.nii | /simulated/path/SIM-0223_PTV_segmentation.nii |
SIM-0224 | 77 | Male | 54.9 | 176.9 | Hypertension | Chemotherapy | Astrocytoma | Intermediate | II | CT | Anisotropic | Non-Contrast-Enhanced | Siemens | 90.2 | 38.85 | 88.6 | Single | 80.02 | Balanced | DVH_P0224 | /simulated/path/P0224_synthetic_image.nii | /simulated/path/SIM-0224_GTV_segmentation.nii | /simulated/path/SIM-0224_CTV_segmentation.nii | /simulated/path/SIM-0224_PTV_segmentation.nii |
SIM-0225 | 83 | Male | 99.7 | 191.2 | Cardiac Issues | Surgery | Astrocytoma | High | I | PET | Anisotropic | Contrast-Enhanced | Siemens | 80 | 183.91 | 136.04 | Single | 74.23 | Organ-Sparing | DVH_P0225 | /simulated/path/P0225_synthetic_image.nii | /simulated/path/SIM-0225_GTV_segmentation.nii | /simulated/path/SIM-0225_CTV_segmentation.nii | /simulated/path/SIM-0225_PTV_segmentation.nii |
SIM-0226 | 36 | Male | 93.2 | 187.9 | Cardiac Issues | Radiotherapy | Astrocytoma | High | III | MRI | Isotropic | Contrast-Enhanced | Siemens | 25.79 | 43.18 | 109.82 | Single | 22.71 | Maximize Tumor Dose | DVH_P0226 | /simulated/path/P0226_synthetic_image.nii | /simulated/path/SIM-0226_GTV_segmentation.nii | /simulated/path/SIM-0226_CTV_segmentation.nii | /simulated/path/SIM-0226_PTV_segmentation.nii |
SIM-0227 | 23 | Male | 85.5 | 178.2 | null | null | Glioblastoma | High | IV | MRI | Isotropic | Contrast-Enhanced | Philips | 98.57 | 90.88 | 32.42 | Multi-Beam | 48.89 | Maximize Tumor Dose | DVH_P0227 | /simulated/path/P0227_synthetic_image.nii | /simulated/path/SIM-0227_GTV_segmentation.nii | /simulated/path/SIM-0227_CTV_segmentation.nii | /simulated/path/SIM-0227_PTV_segmentation.nii |
SIM-0228 | 44 | Male | 74.8 | 160 | Cardiac Issues | Radiotherapy | Astrocytoma | Low | I | MRI | Anisotropic | Contrast-Enhanced | GE | 79.98 | 86.65 | 236 | Single | 94.18 | Organ-Sparing | DVH_P0228 | /simulated/path/P0228_synthetic_image.nii | /simulated/path/SIM-0228_GTV_segmentation.nii | /simulated/path/SIM-0228_CTV_segmentation.nii | /simulated/path/SIM-0228_PTV_segmentation.nii |
SIM-0229 | 86 | Female | 80.3 | 151 | null | Surgery | Glioblastoma | High | I | CT | Isotropic | Contrast-Enhanced | Siemens | 11.6 | 190.81 | 90.64 | Multi-Beam | 48.09 | Balanced | DVH_P0229 | /simulated/path/P0229_synthetic_image.nii | /simulated/path/SIM-0229_GTV_segmentation.nii | /simulated/path/SIM-0229_CTV_segmentation.nii | /simulated/path/SIM-0229_PTV_segmentation.nii |
SIM-0230 | 26 | Male | 68.9 | 150.3 | null | Radiotherapy | Astrocytoma | Intermediate | IV | MRI | Anisotropic | Non-Contrast-Enhanced | Siemens | 139.97 | 175.58 | 13.12 | Multi-Beam | 52.11 | Maximize Tumor Dose | DVH_P0230 | /simulated/path/P0230_synthetic_image.nii | /simulated/path/SIM-0230_GTV_segmentation.nii | /simulated/path/SIM-0230_CTV_segmentation.nii | /simulated/path/SIM-0230_PTV_segmentation.nii |
SIM-0231 | 58 | Female | 73.2 | 171 | Cancer History | Chemotherapy | Glioblastoma | High | I | PET | Isotropic | Contrast-Enhanced | Philips | 126.28 | 91.13 | 166.07 | Single | 98.48 | Organ-Sparing | DVH_P0231 | /simulated/path/P0231_synthetic_image.nii | /simulated/path/SIM-0231_GTV_segmentation.nii | /simulated/path/SIM-0231_CTV_segmentation.nii | /simulated/path/SIM-0231_PTV_segmentation.nii |
SIM-0232 | 41 | Female | 66.6 | 159.9 | null | Chemotherapy | Metastatic | Intermediate | II | MRI | Anisotropic | Contrast-Enhanced | Siemens | 8.07 | 18.21 | 83.99 | Single | 64.05 | Maximize Tumor Dose | DVH_P0232 | /simulated/path/P0232_synthetic_image.nii | /simulated/path/SIM-0232_GTV_segmentation.nii | /simulated/path/SIM-0232_CTV_segmentation.nii | /simulated/path/SIM-0232_PTV_segmentation.nii |
SIM-0233 | 35 | Female | 73 | 180.4 | Cardiac Issues | Surgery | Meningioma | Intermediate | III | PET | Isotropic | Contrast-Enhanced | Philips | 13.63 | 97.98 | 215.47 | Single | 87.73 | Organ-Sparing | DVH_P0233 | /simulated/path/P0233_synthetic_image.nii | /simulated/path/SIM-0233_GTV_segmentation.nii | /simulated/path/SIM-0233_CTV_segmentation.nii | /simulated/path/SIM-0233_PTV_segmentation.nii |
SIM-0234 | 71 | Female | 70.1 | 165 | Cardiac Issues | Surgery | Meningioma | Low | I | MRI | Anisotropic | Non-Contrast-Enhanced | Siemens | 134.73 | 47.35 | 205.75 | Multi-Beam | 10.4 | Balanced | DVH_P0234 | /simulated/path/P0234_synthetic_image.nii | /simulated/path/SIM-0234_GTV_segmentation.nii | /simulated/path/SIM-0234_CTV_segmentation.nii | /simulated/path/SIM-0234_PTV_segmentation.nii |
SIM-0235 | 40 | Male | 64.7 | 179.5 | Cardiac Issues | Surgery | Glioblastoma | Intermediate | III | CT | Isotropic | Non-Contrast-Enhanced | Siemens | 47.77 | 131.03 | 56.41 | Multi-Beam | 66.59 | Organ-Sparing | DVH_P0235 | /simulated/path/P0235_synthetic_image.nii | /simulated/path/SIM-0235_GTV_segmentation.nii | /simulated/path/SIM-0235_CTV_segmentation.nii | /simulated/path/SIM-0235_PTV_segmentation.nii |
SIM-0236 | 49 | Male | 87 | 170 | null | Radiotherapy | Metastatic | High | I | PET | Anisotropic | Contrast-Enhanced | Philips | 112.29 | 141.99 | 23.41 | Single | 83.38 | Balanced | DVH_P0236 | /simulated/path/P0236_synthetic_image.nii | /simulated/path/SIM-0236_GTV_segmentation.nii | /simulated/path/SIM-0236_CTV_segmentation.nii | /simulated/path/SIM-0236_PTV_segmentation.nii |
SIM-0237 | 37 | Female | 88.4 | 168.6 | Cancer History | Chemotherapy | Glioblastoma | Low | IV | CT | Anisotropic | Non-Contrast-Enhanced | GE | 104.03 | 105.29 | 211.18 | Multi-Beam | 30.88 | Balanced | DVH_P0237 | /simulated/path/P0237_synthetic_image.nii | /simulated/path/SIM-0237_GTV_segmentation.nii | /simulated/path/SIM-0237_CTV_segmentation.nii | /simulated/path/SIM-0237_PTV_segmentation.nii |
SIM-0238 | 55 | Male | 72.3 | 155.6 | Diabetes | Chemotherapy | Glioblastoma | High | I | MRI | Anisotropic | Contrast-Enhanced | GE | 48.95 | 157.58 | 76.39 | Single | 17.17 | Balanced | DVH_P0238 | /simulated/path/P0238_synthetic_image.nii | /simulated/path/SIM-0238_GTV_segmentation.nii | /simulated/path/SIM-0238_CTV_segmentation.nii | /simulated/path/SIM-0238_PTV_segmentation.nii |
SIM-0239 | 66 | Female | 83.4 | 157.8 | Hypertension | Chemotherapy | Astrocytoma | Low | III | PET | Isotropic | Contrast-Enhanced | Philips | 44.27 | 117.27 | 59.15 | Multi-Beam | 32.9 | Organ-Sparing | DVH_P0239 | /simulated/path/P0239_synthetic_image.nii | /simulated/path/SIM-0239_GTV_segmentation.nii | /simulated/path/SIM-0239_CTV_segmentation.nii | /simulated/path/SIM-0239_PTV_segmentation.nii |
SIM-0240 | 27 | Female | 68.3 | 163.4 | Hypertension | Radiotherapy | Metastatic | Intermediate | IV | PET | Isotropic | Non-Contrast-Enhanced | GE | 63.81 | 49.63 | 195.17 | Single | 14.61 | Organ-Sparing | DVH_P0240 | /simulated/path/P0240_synthetic_image.nii | /simulated/path/SIM-0240_GTV_segmentation.nii | /simulated/path/SIM-0240_CTV_segmentation.nii | /simulated/path/SIM-0240_PTV_segmentation.nii |
SIM-0241 | 50 | Female | 97.9 | 152.2 | Diabetes | Chemotherapy | Metastatic | Low | III | CT | Isotropic | Non-Contrast-Enhanced | Siemens | 109.28 | 117.52 | 11.15 | Multi-Beam | 77.38 | Organ-Sparing | DVH_P0241 | /simulated/path/P0241_synthetic_image.nii | /simulated/path/SIM-0241_GTV_segmentation.nii | /simulated/path/SIM-0241_CTV_segmentation.nii | /simulated/path/SIM-0241_PTV_segmentation.nii |
SIM-0242 | 41 | Male | 95.7 | 154.4 | Cardiac Issues | null | Astrocytoma | High | IV | MRI | Isotropic | Non-Contrast-Enhanced | GE | 19.62 | 49.15 | 79.33 | Multi-Beam | 84.86 | Maximize Tumor Dose | DVH_P0242 | /simulated/path/P0242_synthetic_image.nii | /simulated/path/SIM-0242_GTV_segmentation.nii | /simulated/path/SIM-0242_CTV_segmentation.nii | /simulated/path/SIM-0242_PTV_segmentation.nii |
SIM-0243 | 72 | Male | 86.2 | 158.2 | Diabetes | Radiotherapy | Metastatic | High | III | PET | Anisotropic | Non-Contrast-Enhanced | Siemens | 143.18 | 17.24 | 82.86 | Single | 97.73 | Balanced | DVH_P0243 | /simulated/path/P0243_synthetic_image.nii | /simulated/path/SIM-0243_GTV_segmentation.nii | /simulated/path/SIM-0243_CTV_segmentation.nii | /simulated/path/SIM-0243_PTV_segmentation.nii |
SIM-0244 | 78 | Male | 90.2 | 150.2 | Diabetes | Surgery | Glioblastoma | High | IV | CT | Isotropic | Contrast-Enhanced | GE | 48.97 | 87.75 | 88.68 | Multi-Beam | 33.27 | Organ-Sparing | DVH_P0244 | /simulated/path/P0244_synthetic_image.nii | /simulated/path/SIM-0244_GTV_segmentation.nii | /simulated/path/SIM-0244_CTV_segmentation.nii | /simulated/path/SIM-0244_PTV_segmentation.nii |
SIM-0245 | 43 | Male | 72.3 | 193.5 | Diabetes | Radiotherapy | Metastatic | Intermediate | II | CT | Anisotropic | Contrast-Enhanced | GE | 146.99 | 193.85 | 52.93 | Single | 70.03 | Maximize Tumor Dose | DVH_P0245 | /simulated/path/P0245_synthetic_image.nii | /simulated/path/SIM-0245_GTV_segmentation.nii | /simulated/path/SIM-0245_CTV_segmentation.nii | /simulated/path/SIM-0245_PTV_segmentation.nii |
SIM-0246 | 53 | Male | 53.4 | 163.3 | Diabetes | Radiotherapy | Metastatic | Low | IV | PET | Isotropic | Contrast-Enhanced | GE | 58.76 | 170.79 | 24.67 | Single | 50.59 | Maximize Tumor Dose | DVH_P0246 | /simulated/path/P0246_synthetic_image.nii | /simulated/path/SIM-0246_GTV_segmentation.nii | /simulated/path/SIM-0246_CTV_segmentation.nii | /simulated/path/SIM-0246_PTV_segmentation.nii |
SIM-0247 | 76 | Female | 60 | 165.4 | Hypertension | Chemotherapy | Astrocytoma | Low | III | PET | Isotropic | Contrast-Enhanced | Philips | 87.63 | 40.77 | 35.23 | Multi-Beam | 17.6 | Organ-Sparing | DVH_P0247 | /simulated/path/P0247_synthetic_image.nii | /simulated/path/SIM-0247_GTV_segmentation.nii | /simulated/path/SIM-0247_CTV_segmentation.nii | /simulated/path/SIM-0247_PTV_segmentation.nii |
SIM-0248 | 24 | Female | 60.3 | 175.4 | Cardiac Issues | null | Metastatic | Intermediate | IV | PET | Anisotropic | Non-Contrast-Enhanced | GE | 141.37 | 62.49 | 139.41 | Single | 46.09 | Balanced | DVH_P0248 | /simulated/path/P0248_synthetic_image.nii | /simulated/path/SIM-0248_GTV_segmentation.nii | /simulated/path/SIM-0248_CTV_segmentation.nii | /simulated/path/SIM-0248_PTV_segmentation.nii |
SIM-0249 | 26 | Female | 85 | 153.9 | Hypertension | Surgery | Metastatic | Low | I | PET | Anisotropic | Contrast-Enhanced | GE | 130.78 | 160.97 | 124.61 | Single | 90.33 | Maximize Tumor Dose | DVH_P0249 | /simulated/path/P0249_synthetic_image.nii | /simulated/path/SIM-0249_GTV_segmentation.nii | /simulated/path/SIM-0249_CTV_segmentation.nii | /simulated/path/SIM-0249_PTV_segmentation.nii |
SIM-0250 | 54 | Male | 73.3 | 195.3 | Cardiac Issues | null | Glioblastoma | Low | IV | MRI | Anisotropic | Contrast-Enhanced | Philips | 38.23 | 87.94 | 89.85 | Multi-Beam | 30.3 | Maximize Tumor Dose | DVH_P0250 | /simulated/path/P0250_synthetic_image.nii | /simulated/path/SIM-0250_GTV_segmentation.nii | /simulated/path/SIM-0250_CTV_segmentation.nii | /simulated/path/SIM-0250_PTV_segmentation.nii |
SIM-0251 | 37 | Male | 80.5 | 173.4 | Cancer History | Surgery | Metastatic | Low | III | PET | Isotropic | Non-Contrast-Enhanced | Philips | 74.97 | 22.65 | 37.62 | Single | 24.9 | Balanced | DVH_P0251 | /simulated/path/P0251_synthetic_image.nii | /simulated/path/SIM-0251_GTV_segmentation.nii | /simulated/path/SIM-0251_CTV_segmentation.nii | /simulated/path/SIM-0251_PTV_segmentation.nii |
SIM-0252 | 21 | Female | 51.6 | 167.5 | Diabetes | Chemotherapy | Glioblastoma | Low | III | CT | Isotropic | Non-Contrast-Enhanced | Philips | 100.52 | 91.15 | 120.84 | Single | 28.22 | Balanced | DVH_P0252 | /simulated/path/P0252_synthetic_image.nii | /simulated/path/SIM-0252_GTV_segmentation.nii | /simulated/path/SIM-0252_CTV_segmentation.nii | /simulated/path/SIM-0252_PTV_segmentation.nii |
SIM-0253 | 80 | Female | 89.8 | 168.5 | Cardiac Issues | Chemotherapy | Meningioma | Low | II | CT | Anisotropic | Contrast-Enhanced | GE | 70.94 | 57.83 | 190.19 | Single | 95.65 | Balanced | DVH_P0253 | /simulated/path/P0253_synthetic_image.nii | /simulated/path/SIM-0253_GTV_segmentation.nii | /simulated/path/SIM-0253_CTV_segmentation.nii | /simulated/path/SIM-0253_PTV_segmentation.nii |
SIM-0254 | 38 | Male | 69.7 | 162.9 | null | Radiotherapy | Glioblastoma | Intermediate | II | PET | Isotropic | Contrast-Enhanced | GE | 1.22 | 22.2 | 236.19 | Single | 49.64 | Maximize Tumor Dose | DVH_P0254 | /simulated/path/P0254_synthetic_image.nii | /simulated/path/SIM-0254_GTV_segmentation.nii | /simulated/path/SIM-0254_CTV_segmentation.nii | /simulated/path/SIM-0254_PTV_segmentation.nii |
SIM-0255 | 42 | Female | 71.4 | 191 | null | null | Meningioma | High | II | MRI | Anisotropic | Contrast-Enhanced | Siemens | 126.42 | 42.97 | 218.28 | Single | 66.5 | Organ-Sparing | DVH_P0255 | /simulated/path/P0255_synthetic_image.nii | /simulated/path/SIM-0255_GTV_segmentation.nii | /simulated/path/SIM-0255_CTV_segmentation.nii | /simulated/path/SIM-0255_PTV_segmentation.nii |
SIM-0256 | 58 | Female | 52.7 | 181.7 | Cancer History | Surgery | Meningioma | Intermediate | I | PET | Isotropic | Non-Contrast-Enhanced | Philips | 15.72 | 139.91 | 116.98 | Single | 55.35 | Balanced | DVH_P0256 | /simulated/path/P0256_synthetic_image.nii | /simulated/path/SIM-0256_GTV_segmentation.nii | /simulated/path/SIM-0256_CTV_segmentation.nii | /simulated/path/SIM-0256_PTV_segmentation.nii |
SIM-0257 | 71 | Female | 83.5 | 170.6 | Hypertension | Radiotherapy | Glioblastoma | Low | II | CT | Anisotropic | Contrast-Enhanced | GE | 20.67 | 132.15 | 181.25 | Single | 85.87 | Maximize Tumor Dose | DVH_P0257 | /simulated/path/P0257_synthetic_image.nii | /simulated/path/SIM-0257_GTV_segmentation.nii | /simulated/path/SIM-0257_CTV_segmentation.nii | /simulated/path/SIM-0257_PTV_segmentation.nii |
SIM-0258 | 33 | Female | 75.8 | 185.2 | Hypertension | Radiotherapy | Astrocytoma | High | IV | CT | Anisotropic | Non-Contrast-Enhanced | Siemens | 93.05 | 169.5 | 116.04 | Multi-Beam | 45.14 | Maximize Tumor Dose | DVH_P0258 | /simulated/path/P0258_synthetic_image.nii | /simulated/path/SIM-0258_GTV_segmentation.nii | /simulated/path/SIM-0258_CTV_segmentation.nii | /simulated/path/SIM-0258_PTV_segmentation.nii |
SIM-0259 | 30 | Female | 95.2 | 174.6 | Cancer History | Chemotherapy | Meningioma | High | IV | PET | Anisotropic | Non-Contrast-Enhanced | GE | 60.91 | 79.49 | 172.6 | Single | 20.8 | Maximize Tumor Dose | DVH_P0259 | /simulated/path/P0259_synthetic_image.nii | /simulated/path/SIM-0259_GTV_segmentation.nii | /simulated/path/SIM-0259_CTV_segmentation.nii | /simulated/path/SIM-0259_PTV_segmentation.nii |
SIM-0260 | 20 | Male | 63.6 | 188.1 | Hypertension | Surgery | Astrocytoma | Low | IV | MRI | Anisotropic | Non-Contrast-Enhanced | Siemens | 135.71 | 114.87 | 168.05 | Multi-Beam | 16.54 | Maximize Tumor Dose | DVH_P0260 | /simulated/path/P0260_synthetic_image.nii | /simulated/path/SIM-0260_GTV_segmentation.nii | /simulated/path/SIM-0260_CTV_segmentation.nii | /simulated/path/SIM-0260_PTV_segmentation.nii |
SIM-0261 | 28 | Female | 70.2 | 198 | Hypertension | Surgery | Astrocytoma | High | II | MRI | Isotropic | Contrast-Enhanced | Siemens | 110.18 | 102.14 | 20.37 | Multi-Beam | 67.68 | Organ-Sparing | DVH_P0261 | /simulated/path/P0261_synthetic_image.nii | /simulated/path/SIM-0261_GTV_segmentation.nii | /simulated/path/SIM-0261_CTV_segmentation.nii | /simulated/path/SIM-0261_PTV_segmentation.nii |
SIM-0262 | 78 | Female | 86.7 | 158.4 | Cardiac Issues | Chemotherapy | Astrocytoma | High | II | MRI | Isotropic | Contrast-Enhanced | GE | 45.88 | 79.99 | 106.23 | Multi-Beam | 77.29 | Maximize Tumor Dose | DVH_P0262 | /simulated/path/P0262_synthetic_image.nii | /simulated/path/SIM-0262_GTV_segmentation.nii | /simulated/path/SIM-0262_CTV_segmentation.nii | /simulated/path/SIM-0262_PTV_segmentation.nii |
SIM-0263 | 74 | Female | 61.3 | 182.8 | Diabetes | Chemotherapy | Metastatic | Intermediate | II | CT | Isotropic | Contrast-Enhanced | Philips | 15.99 | 15.8 | 202.25 | Multi-Beam | 77.48 | Organ-Sparing | DVH_P0263 | /simulated/path/P0263_synthetic_image.nii | /simulated/path/SIM-0263_GTV_segmentation.nii | /simulated/path/SIM-0263_CTV_segmentation.nii | /simulated/path/SIM-0263_PTV_segmentation.nii |
SIM-0264 | 76 | Female | 70.3 | 169.9 | Cardiac Issues | null | Glioblastoma | Intermediate | I | CT | Isotropic | Non-Contrast-Enhanced | GE | 58.98 | 40.44 | 32.25 | Multi-Beam | 62.82 | Balanced | DVH_P0264 | /simulated/path/P0264_synthetic_image.nii | /simulated/path/SIM-0264_GTV_segmentation.nii | /simulated/path/SIM-0264_CTV_segmentation.nii | /simulated/path/SIM-0264_PTV_segmentation.nii |
SIM-0265 | 32 | Female | 86.2 | 165.8 | Hypertension | Radiotherapy | Metastatic | Intermediate | IV | PET | Isotropic | Contrast-Enhanced | Siemens | 49.89 | 110.93 | 3.47 | Multi-Beam | 31.42 | Balanced | DVH_P0265 | /simulated/path/P0265_synthetic_image.nii | /simulated/path/SIM-0265_GTV_segmentation.nii | /simulated/path/SIM-0265_CTV_segmentation.nii | /simulated/path/SIM-0265_PTV_segmentation.nii |
SIM-0266 | 65 | Female | 52.3 | 152.2 | Diabetes | null | Metastatic | High | I | CT | Anisotropic | Contrast-Enhanced | Siemens | 132.6 | 171.19 | 172.81 | Single | 53.8 | Balanced | DVH_P0266 | /simulated/path/P0266_synthetic_image.nii | /simulated/path/SIM-0266_GTV_segmentation.nii | /simulated/path/SIM-0266_CTV_segmentation.nii | /simulated/path/SIM-0266_PTV_segmentation.nii |
SIM-0267 | 59 | Female | 53 | 168.6 | null | null | Glioblastoma | Intermediate | II | PET | Isotropic | Contrast-Enhanced | Siemens | 26.42 | 148.35 | 160.69 | Single | 23.45 | Organ-Sparing | DVH_P0267 | /simulated/path/P0267_synthetic_image.nii | /simulated/path/SIM-0267_GTV_segmentation.nii | /simulated/path/SIM-0267_CTV_segmentation.nii | /simulated/path/SIM-0267_PTV_segmentation.nii |
SIM-0268 | 89 | Male | 79.1 | 162.2 | Cardiac Issues | Radiotherapy | Metastatic | Low | IV | CT | Isotropic | Contrast-Enhanced | GE | 147.46 | 133.73 | 46.32 | Multi-Beam | 16.12 | Maximize Tumor Dose | DVH_P0268 | /simulated/path/P0268_synthetic_image.nii | /simulated/path/SIM-0268_GTV_segmentation.nii | /simulated/path/SIM-0268_CTV_segmentation.nii | /simulated/path/SIM-0268_PTV_segmentation.nii |
SIM-0269 | 19 | Female | 86.3 | 192.4 | Hypertension | Surgery | Astrocytoma | Low | II | MRI | Isotropic | Contrast-Enhanced | Siemens | 15.55 | 113.25 | 63.8 | Multi-Beam | 68.81 | Maximize Tumor Dose | DVH_P0269 | /simulated/path/P0269_synthetic_image.nii | /simulated/path/SIM-0269_GTV_segmentation.nii | /simulated/path/SIM-0269_CTV_segmentation.nii | /simulated/path/SIM-0269_PTV_segmentation.nii |
SIM-0270 | 36 | Male | 84.9 | 154.3 | Cancer History | Radiotherapy | Astrocytoma | Intermediate | I | PET | Isotropic | Non-Contrast-Enhanced | GE | 98.43 | 21.4 | 168.93 | Multi-Beam | 21.84 | Maximize Tumor Dose | DVH_P0270 | /simulated/path/P0270_synthetic_image.nii | /simulated/path/SIM-0270_GTV_segmentation.nii | /simulated/path/SIM-0270_CTV_segmentation.nii | /simulated/path/SIM-0270_PTV_segmentation.nii |
SIM-0271 | 64 | Male | 58.8 | 175.3 | null | Chemotherapy | Meningioma | Intermediate | I | CT | Isotropic | Non-Contrast-Enhanced | Siemens | 116.66 | 181.19 | 219.15 | Multi-Beam | 63.37 | Balanced | DVH_P0271 | /simulated/path/P0271_synthetic_image.nii | /simulated/path/SIM-0271_GTV_segmentation.nii | /simulated/path/SIM-0271_CTV_segmentation.nii | /simulated/path/SIM-0271_PTV_segmentation.nii |
SIM-0272 | 36 | Female | 54.3 | 151.6 | Hypertension | Chemotherapy | Astrocytoma | High | II | PET | Anisotropic | Contrast-Enhanced | Philips | 87.11 | 20.85 | 95 | Single | 19.6 | Balanced | DVH_P0272 | /simulated/path/P0272_synthetic_image.nii | /simulated/path/SIM-0272_GTV_segmentation.nii | /simulated/path/SIM-0272_CTV_segmentation.nii | /simulated/path/SIM-0272_PTV_segmentation.nii |
SIM-0273 | 45 | Male | 54.9 | 197.5 | null | null | Meningioma | Intermediate | III | CT | Anisotropic | Contrast-Enhanced | GE | 101.49 | 11.09 | 1.47 | Multi-Beam | 29.48 | Organ-Sparing | DVH_P0273 | /simulated/path/P0273_synthetic_image.nii | /simulated/path/SIM-0273_GTV_segmentation.nii | /simulated/path/SIM-0273_CTV_segmentation.nii | /simulated/path/SIM-0273_PTV_segmentation.nii |
SIM-0274 | 49 | Male | 83.2 | 176.8 | Cardiac Issues | Surgery | Glioblastoma | High | I | PET | Isotropic | Non-Contrast-Enhanced | GE | 57.59 | 93.34 | 194 | Multi-Beam | 23.56 | Balanced | DVH_P0274 | /simulated/path/P0274_synthetic_image.nii | /simulated/path/SIM-0274_GTV_segmentation.nii | /simulated/path/SIM-0274_CTV_segmentation.nii | /simulated/path/SIM-0274_PTV_segmentation.nii |
SIM-0275 | 23 | Female | 82.4 | 198.1 | Cancer History | Surgery | Astrocytoma | Low | I | PET | Isotropic | Contrast-Enhanced | Philips | 12.42 | 75.44 | 222.08 | Multi-Beam | 31.65 | Maximize Tumor Dose | DVH_P0275 | /simulated/path/P0275_synthetic_image.nii | /simulated/path/SIM-0275_GTV_segmentation.nii | /simulated/path/SIM-0275_CTV_segmentation.nii | /simulated/path/SIM-0275_PTV_segmentation.nii |
SIM-0276 | 31 | Female | 74.9 | 155.5 | Cancer History | null | Astrocytoma | Intermediate | II | MRI | Anisotropic | Contrast-Enhanced | GE | 10.66 | 85.54 | 42.27 | Single | 85.52 | Balanced | DVH_P0276 | /simulated/path/P0276_synthetic_image.nii | /simulated/path/SIM-0276_GTV_segmentation.nii | /simulated/path/SIM-0276_CTV_segmentation.nii | /simulated/path/SIM-0276_PTV_segmentation.nii |
SIM-0277 | 62 | Male | 92.3 | 169.3 | null | Chemotherapy | Metastatic | Intermediate | III | PET | Isotropic | Non-Contrast-Enhanced | Philips | 84.14 | 105.14 | 196.73 | Single | 21.82 | Organ-Sparing | DVH_P0277 | /simulated/path/P0277_synthetic_image.nii | /simulated/path/SIM-0277_GTV_segmentation.nii | /simulated/path/SIM-0277_CTV_segmentation.nii | /simulated/path/SIM-0277_PTV_segmentation.nii |
SIM-0278 | 21 | Male | 73.8 | 160.6 | null | null | Meningioma | High | II | CT | Anisotropic | Non-Contrast-Enhanced | GE | 76.38 | 88 | 87.15 | Single | 23.07 | Maximize Tumor Dose | DVH_P0278 | /simulated/path/P0278_synthetic_image.nii | /simulated/path/SIM-0278_GTV_segmentation.nii | /simulated/path/SIM-0278_CTV_segmentation.nii | /simulated/path/SIM-0278_PTV_segmentation.nii |
SIM-0279 | 84 | Male | 93.9 | 174.9 | Cancer History | Chemotherapy | Glioblastoma | Low | II | CT | Anisotropic | Contrast-Enhanced | Philips | 71.06 | 145.47 | 18.83 | Multi-Beam | 13 | Organ-Sparing | DVH_P0279 | /simulated/path/P0279_synthetic_image.nii | /simulated/path/SIM-0279_GTV_segmentation.nii | /simulated/path/SIM-0279_CTV_segmentation.nii | /simulated/path/SIM-0279_PTV_segmentation.nii |
SIM-0280 | 33 | Female | 100 | 172 | null | Chemotherapy | Meningioma | Low | IV | PET | Isotropic | Non-Contrast-Enhanced | Philips | 15.99 | 25.04 | 61.3 | Multi-Beam | 54.9 | Balanced | DVH_P0280 | /simulated/path/P0280_synthetic_image.nii | /simulated/path/SIM-0280_GTV_segmentation.nii | /simulated/path/SIM-0280_CTV_segmentation.nii | /simulated/path/SIM-0280_PTV_segmentation.nii |
SIM-0281 | 38 | Female | 94.5 | 156 | Cancer History | Radiotherapy | Astrocytoma | High | IV | PET | Isotropic | Non-Contrast-Enhanced | Siemens | 124.05 | 133.15 | 168.61 | Multi-Beam | 68.96 | Organ-Sparing | DVH_P0281 | /simulated/path/P0281_synthetic_image.nii | /simulated/path/SIM-0281_GTV_segmentation.nii | /simulated/path/SIM-0281_CTV_segmentation.nii | /simulated/path/SIM-0281_PTV_segmentation.nii |
SIM-0282 | 41 | Female | 55.6 | 181.3 | Hypertension | Chemotherapy | Metastatic | High | II | MRI | Isotropic | Non-Contrast-Enhanced | Siemens | 42.44 | 145.65 | 197.05 | Multi-Beam | 21.56 | Maximize Tumor Dose | DVH_P0282 | /simulated/path/P0282_synthetic_image.nii | /simulated/path/SIM-0282_GTV_segmentation.nii | /simulated/path/SIM-0282_CTV_segmentation.nii | /simulated/path/SIM-0282_PTV_segmentation.nii |
SIM-0283 | 49 | Male | 56.5 | 168.8 | Cancer History | Radiotherapy | Metastatic | Intermediate | II | PET | Isotropic | Non-Contrast-Enhanced | GE | 9.44 | 156.64 | 56.98 | Multi-Beam | 34.31 | Organ-Sparing | DVH_P0283 | /simulated/path/P0283_synthetic_image.nii | /simulated/path/SIM-0283_GTV_segmentation.nii | /simulated/path/SIM-0283_CTV_segmentation.nii | /simulated/path/SIM-0283_PTV_segmentation.nii |
SIM-0284 | 60 | Female | 54 | 190.1 | Hypertension | null | Glioblastoma | High | II | MRI | Anisotropic | Contrast-Enhanced | GE | 111.09 | 129.05 | 4.76 | Single | 75.07 | Organ-Sparing | DVH_P0284 | /simulated/path/P0284_synthetic_image.nii | /simulated/path/SIM-0284_GTV_segmentation.nii | /simulated/path/SIM-0284_CTV_segmentation.nii | /simulated/path/SIM-0284_PTV_segmentation.nii |
SIM-0285 | 42 | Male | 74.9 | 191.9 | Diabetes | null | Glioblastoma | High | III | MRI | Anisotropic | Non-Contrast-Enhanced | Siemens | 27.9 | 136.99 | 34.06 | Single | 34.13 | Maximize Tumor Dose | DVH_P0285 | /simulated/path/P0285_synthetic_image.nii | /simulated/path/SIM-0285_GTV_segmentation.nii | /simulated/path/SIM-0285_CTV_segmentation.nii | /simulated/path/SIM-0285_PTV_segmentation.nii |
SIM-0286 | 56 | Male | 88.9 | 152.9 | Diabetes | Surgery | Astrocytoma | Low | II | PET | Isotropic | Contrast-Enhanced | Siemens | 136.68 | 171.91 | 177.82 | Single | 31.14 | Maximize Tumor Dose | DVH_P0286 | /simulated/path/P0286_synthetic_image.nii | /simulated/path/SIM-0286_GTV_segmentation.nii | /simulated/path/SIM-0286_CTV_segmentation.nii | /simulated/path/SIM-0286_PTV_segmentation.nii |
SIM-0287 | 36 | Male | 63.6 | 172 | Cancer History | Chemotherapy | Astrocytoma | Intermediate | I | MRI | Anisotropic | Contrast-Enhanced | GE | 111.03 | 179.93 | 234.31 | Multi-Beam | 24.09 | Balanced | DVH_P0287 | /simulated/path/P0287_synthetic_image.nii | /simulated/path/SIM-0287_GTV_segmentation.nii | /simulated/path/SIM-0287_CTV_segmentation.nii | /simulated/path/SIM-0287_PTV_segmentation.nii |
SIM-0288 | 84 | Female | 98.5 | 168.8 | Hypertension | Radiotherapy | Meningioma | Low | III | PET | Isotropic | Non-Contrast-Enhanced | Siemens | 129.58 | 104.93 | 155.34 | Single | 46.42 | Balanced | DVH_P0288 | /simulated/path/P0288_synthetic_image.nii | /simulated/path/SIM-0288_GTV_segmentation.nii | /simulated/path/SIM-0288_CTV_segmentation.nii | /simulated/path/SIM-0288_PTV_segmentation.nii |
SIM-0289 | 33 | Female | 64.1 | 183.2 | Diabetes | null | Glioblastoma | High | IV | PET | Isotropic | Non-Contrast-Enhanced | Philips | 119.2 | 41.65 | 37.09 | Single | 46.13 | Maximize Tumor Dose | DVH_P0289 | /simulated/path/P0289_synthetic_image.nii | /simulated/path/SIM-0289_GTV_segmentation.nii | /simulated/path/SIM-0289_CTV_segmentation.nii | /simulated/path/SIM-0289_PTV_segmentation.nii |
SIM-0290 | 63 | Male | 60.8 | 175.1 | null | Surgery | Meningioma | High | II | PET | Anisotropic | Non-Contrast-Enhanced | Siemens | 39.29 | 43.59 | 206.87 | Multi-Beam | 78.84 | Balanced | DVH_P0290 | /simulated/path/P0290_synthetic_image.nii | /simulated/path/SIM-0290_GTV_segmentation.nii | /simulated/path/SIM-0290_CTV_segmentation.nii | /simulated/path/SIM-0290_PTV_segmentation.nii |
SIM-0291 | 60 | Female | 92.9 | 172.3 | Cancer History | Chemotherapy | Meningioma | Intermediate | III | MRI | Isotropic | Contrast-Enhanced | GE | 63.51 | 198.94 | 232.36 | Multi-Beam | 39.25 | Organ-Sparing | DVH_P0291 | /simulated/path/P0291_synthetic_image.nii | /simulated/path/SIM-0291_GTV_segmentation.nii | /simulated/path/SIM-0291_CTV_segmentation.nii | /simulated/path/SIM-0291_PTV_segmentation.nii |
SIM-0292 | 30 | Female | 57.1 | 186.4 | Cardiac Issues | Chemotherapy | Metastatic | High | I | CT | Isotropic | Contrast-Enhanced | Siemens | 82.21 | 67.13 | 153.52 | Single | 94 | Maximize Tumor Dose | DVH_P0292 | /simulated/path/P0292_synthetic_image.nii | /simulated/path/SIM-0292_GTV_segmentation.nii | /simulated/path/SIM-0292_CTV_segmentation.nii | /simulated/path/SIM-0292_PTV_segmentation.nii |
SIM-0293 | 49 | Male | 85.4 | 183.4 | Diabetes | Chemotherapy | Glioblastoma | Low | IV | MRI | Anisotropic | Contrast-Enhanced | Philips | 21.16 | 156.13 | 203.09 | Single | 54.95 | Maximize Tumor Dose | DVH_P0293 | /simulated/path/P0293_synthetic_image.nii | /simulated/path/SIM-0293_GTV_segmentation.nii | /simulated/path/SIM-0293_CTV_segmentation.nii | /simulated/path/SIM-0293_PTV_segmentation.nii |
SIM-0294 | 44 | Male | 72 | 183.2 | Hypertension | null | Glioblastoma | Low | II | PET | Isotropic | Contrast-Enhanced | Siemens | 85.39 | 84.18 | 44.43 | Single | 82.79 | Maximize Tumor Dose | DVH_P0294 | /simulated/path/P0294_synthetic_image.nii | /simulated/path/SIM-0294_GTV_segmentation.nii | /simulated/path/SIM-0294_CTV_segmentation.nii | /simulated/path/SIM-0294_PTV_segmentation.nii |
SIM-0295 | 65 | Male | 72.1 | 181.8 | Diabetes | Chemotherapy | Astrocytoma | High | II | MRI | Isotropic | Contrast-Enhanced | Philips | 140.61 | 27.01 | 215.9 | Multi-Beam | 48.76 | Organ-Sparing | DVH_P0295 | /simulated/path/P0295_synthetic_image.nii | /simulated/path/SIM-0295_GTV_segmentation.nii | /simulated/path/SIM-0295_CTV_segmentation.nii | /simulated/path/SIM-0295_PTV_segmentation.nii |
SIM-0296 | 75 | Male | 64.6 | 180.6 | Diabetes | Chemotherapy | Glioblastoma | High | IV | CT | Anisotropic | Contrast-Enhanced | GE | 132.24 | 0.96 | 109.17 | Single | 54.76 | Maximize Tumor Dose | DVH_P0296 | /simulated/path/P0296_synthetic_image.nii | /simulated/path/SIM-0296_GTV_segmentation.nii | /simulated/path/SIM-0296_CTV_segmentation.nii | /simulated/path/SIM-0296_PTV_segmentation.nii |
SIM-0297 | 32 | Female | 86.9 | 179.9 | Diabetes | Chemotherapy | Astrocytoma | Low | IV | CT | Anisotropic | Non-Contrast-Enhanced | Siemens | 43.3 | 17.11 | 65.6 | Multi-Beam | 14.94 | Maximize Tumor Dose | DVH_P0297 | /simulated/path/P0297_synthetic_image.nii | /simulated/path/SIM-0297_GTV_segmentation.nii | /simulated/path/SIM-0297_CTV_segmentation.nii | /simulated/path/SIM-0297_PTV_segmentation.nii |
SIM-0298 | 40 | Female | 77.7 | 162.4 | Cardiac Issues | Chemotherapy | Glioblastoma | Intermediate | IV | MRI | Isotropic | Non-Contrast-Enhanced | GE | 26.84 | 85.2 | 82.34 | Single | 72.47 | Organ-Sparing | DVH_P0298 | /simulated/path/P0298_synthetic_image.nii | /simulated/path/SIM-0298_GTV_segmentation.nii | /simulated/path/SIM-0298_CTV_segmentation.nii | /simulated/path/SIM-0298_PTV_segmentation.nii |
SIM-0299 | 75 | Male | 88.1 | 179.4 | null | Radiotherapy | Astrocytoma | Low | III | CT | Anisotropic | Contrast-Enhanced | Siemens | 81.71 | 50.7 | 220.79 | Single | 41.47 | Balanced | DVH_P0299 | /simulated/path/P0299_synthetic_image.nii | /simulated/path/SIM-0299_GTV_segmentation.nii | /simulated/path/SIM-0299_CTV_segmentation.nii | /simulated/path/SIM-0299_PTV_segmentation.nii |
SIM-0300 | 89 | Female | 76.1 | 180.3 | null | null | Metastatic | Intermediate | III | MRI | Isotropic | Non-Contrast-Enhanced | Siemens | 41.89 | 79.27 | 226.34 | Single | 50.45 | Organ-Sparing | DVH_P0300 | /simulated/path/P0300_synthetic_image.nii | /simulated/path/SIM-0300_GTV_segmentation.nii | /simulated/path/SIM-0300_CTV_segmentation.nii | /simulated/path/SIM-0300_PTV_segmentation.nii |